Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of DRM01B Topical Gel in Acne Vulgaris
NCT01936324Phase 2Completed
- Sponsor
- Dermira, Inc.
- Start
- Aug 2013
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of olumacostat glasaretil in acne vulgaris, sponsored by Dermira, Inc.. Started Aug 2013; status: completed.
02
Drugs
olumacostat glasaretil
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT01936324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01936324.